RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA
Clinical trials for RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemia: experimental drug combo enters human testing
Disease control Recruiting nowThis study tests a new drug called lisaftoclax, alone or combined with other medicines, in people with acute myeloid leukemia that has come back or not responded to treatment. The main goals are to check safety and find the best dose. About 682 adults will take part across multip…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for tough leukemia: Three-Drug combo trial launches
Disease control Recruiting nowThis phase 2 trial is testing a combination of three drugs—mitoxantrone liposome, cytarabine, and venetoclax—in 72 adults with acute myeloid leukemia that has come back or not responded to treatment. The goal is to see if this combo can help more patients achieve complete remissi…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 26, 2026 17:42 UTC